Haplotype Labs vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionHaplotype LabsIsomorphic Labs
PricingContact-based (SaaS)Contact-based (pharma partnerships)
Target userPopulation genetics researchers, precision medicine developersLarge pharma companies
Core technologyPolygenic risk score modeling, SaaSAlphaFold-based predictive & generative AI
FundingY Combinator-backed$600M external investment round (2025), Series B (2026)
DeploymentWeb-based, no local installPartner-integrated, no standalone product
Latest milestoneNoneSeries B (2026), J&J collaboration (2026)

For precision medicine developers needing affordable, scalable polygenic risk analysis, Haplotype Labs offers a turnkey SaaS with 50-90% cost reduction. Isomorphic Labs, with its AlphaFold-driven Drug Design Engine and deep pharma partnerships, is the choice for large-scale drug discovery programs, but is inaccessible to individual researchers due to its partnership-only model.

Haplotype Labs
Haplotype Labs

SaaS platform that reduces sequencing costs 50-90% with polygenic risk modeling.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
3 views
7.4k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
Categories
🧬 Drug Discovery & Life Sciences📊 Data & Analytics
🧬 Drug Discovery & Life Sciences
Features
Polygenic risk score (PRS) modeling
Disease risk prediction and detection
Population genetics analysis
Reduce sequencing costs by 50-90%
Eliminate bespoke software pipelines
Accelerate research timelines
Secure genetics data processing
Machine learning integration
Collaborative research platform
Community-driven tooling
SaaS-based workflow (no local install)
Web-based interface
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: Haplotype Labs vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Haplotype Labs

0 mentions · mixed

What users praise

  • Promises to cut sequencing costs by 50-90%
  • Founder has deep expertise from 23andMe
  • Aims to eliminate bespoke software pipelines
  • Targets critical need in polygenic risk prediction

What frustrates them

  • No user reviews on any platform exist yet
  • Unproven reliability and performance claims
  • Pricing is opaque, no free tier available
  • No integration details for popular genomics tools

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Population genetics researcher
    Pick: Haplotype Labs

    The platform reduces sequencing costs by 50-90% and provides polygenic risk models without requiring custom software pipelines.

  • Large pharma drug discovery team
    Pick: Isomorphic Labs

    Isomorphic Labs partners with pharma giants like Novartis and J&J, leveraging AlphaFold for advanced drug design at scale.

  • Solo precision medicine startup
    Pick: Haplotype Labs

    Affordable SaaS without upfront partnership commitment, enabling early-stage R&D.

  • Late-stage pipeline requiring accelerated lead optimization
    Pick: Isomorphic Labs

    Its Drug Design Engine combines predictive and generative AI to iterate rapidly, as seen in its pharma collaborations.

  • Academic institution without pharma ties
    Pick: Haplotype Labs

    No need for partnerships; web-based interface and community-driven tooling suit academic research.

Frequently Asked Questions

Haplotype Labs vs Isomorphic Labs: which should you choose?

For precision medicine developers needing affordable, scalable polygenic risk analysis, Haplotype Labs offers a turnkey SaaS with 50-90% cost reduction. Isomorphic Labs, with its AlphaFold-driven Drug Design Engine and deep pharma partnerships, is the choice for large-scale drug discovery programs, but is inaccessible to individual researchers due to its partnership-only model.

Can I use Isomorphic Labs as an individual researcher?

No, Isomorphic Labs operates solely through deep pharma partnerships and does not offer a standalone product.

Does Haplotype Labs require coding skills?

No, it is a SaaS platform with a web-based interface that eliminates bespoke software pipelines.

Is Isomorphic Labs based on AlphaFold?

Yes, it builds on the Nobel Prize-winning AlphaFold system and extends it with predictive and generative AI models.

Which tool is better for cost reduction?

Haplotype Labs explicitly reduces sequencing costs by 50-90%, while Isomorphic Labs focuses on drug discovery ROI.

Can Haplotype Labs be used for drug discovery?

Its polygenic risk models are more suited for disease prediction and prevention, not direct drug molecule design.

What is the latest funding news for Isomorphic Labs?

It raised a $600M external investment round in March 2025 and closed a Series B in February 2026.

Does Haplotype Labs have any notable partnerships?

No recent news indicates partnerships; it is Y Combinator-backed and targets researchers directly.

Are these tools compliant with genetics data security?

Haplotype Labs emphasizes secure genetics data processing; Isomorphic Labs partners with pharma to ensure compliance.

More Haplotype Labs or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026